Drug that ‘melts away’ tumours hailed as ‘gamechanger’ for some bowel cancer patients

Pembrolizumab triples chance of survival for the 10-15% of patients with the right genetic makeup, study finds

A gamechanger" immunotherapy drug that melts away" tumours dramatically increases the chances of curing some bowel cancers and may even replace the need for surgery, doctors have said.

Pembrolizumab targets and blocks a specific protein on the surface of immune cells that then seek out and destroy cancer cells.